Atrosimab (ATM-001) is an Fv-Fc1kappa fusion protein that binds strongly to human TNFR1 with an EC50 value of 0.37 nM. It effectively inhibits TNF-induced activation of TNFR1 and holds potential for research in chronic inflammatory diseases.
Target:
TNF
* VAT and and shipping costs not included. Errors and price changes excepted